Required Courses (25 q.h.)*
|
RGA 6100
|
Introduction to Drug and Medical Device Regulation |
4 q.h. |
|
BTC 6210
|
Human Experimentation: Methodological Issues Fundamental to Clinical Trials |
4 q.h. |
|
RGA 6201
|
New Drug Development: A QA Regulatory Overview |
4 q.h. |
|
RGA 6202
|
Medical Device Development: A QA Regulatory Overview |
4 q.h. |
|
RGA 6200
|
Biologics Development: A QA Regulatory Overview |
4 q.h. |
|
RGA 6203
|
Food, Drug, and Medical Device Law: Topics and Cases
(This course should be taken as the final required course.)
|
5 q.h. |
*Please note: completion of RGA 6280: Advanced Writing on International Biomedical Topics may be required of students as a condition for their continued enrollment in this program.
Choose one of the following Safety and Surveillance courses (4 q.h.)
|
BTC 6211
|
Validation and Auditing of Clinical Trial Information |
4 q.h. |
|
RGA 6212
|
Safety Sciences 1: Introduction to Safety and Surveillance |
4 q.h. |
|
RGA 6213
|
Safety Sciences 2: Safety Surveillance, Pharmacoepidemiology, Risk |
4 q.h. |
|
RGA 6230
|
Clinical Laboratory Management in Clinical Trials |
4 q.h. |
|
RGA 6280
|
Advanced Writing on International Biomedical Topics
Please note: completion of this course may be required of students as a condition for their continued enrollment in this program.
|
4 q.h. |
|
TCC 6310
|
Regulatory Documentation Processes |
4 q.h. |
|
TCC 6370
|
Regulatory Writing: Medical Device Submissions |
4 q.h. |
|
TCC 6380
|
Regulatory Writing: New Drug Applications |
4 q.h. |
|
RGA6233 |
Application of Quality System Regulation in Medical Device Design and Manufacturing |
4 q.h. |
|
RGA6234
|
Drug and Device Supplier Risk Management Compliance and Processes |
4 q.h. |
Choose one of the following Business and Law courses (4 q.h.)
|
BTC 6260
|
The Business of Medicine and Biotechnology |
4 q.h. |
|
RGA 6110
|
Understanding the Health-Care Landscape |
4 q.h. |
|
RGA 6214
|
Food and Drug Administration: Creation, Behavior, and Regulatory Culture |
4 q.h. |
|
RGA 6216
|
Medical, Social, and Financial Dimensions of Orphan Drugs |
4 q.h. |
|
RGA 6217
|
Biomedical Product Development: From Biotech to Boardroom to Market |
4 q.h. |
|
RGA 6218
|
Regulatory Affairs in an Entrepreneurial Environment |
4 q.h. |
|
RGA 6219
|
Advertising and Promotion of Drugs and Medical Device Products |
4 q.h. |
|
RGA 6235
|
Emerging Product Categories in the Regulation of Drugs and Biologics |
4 q.h. |
Choose from one of the following Development and Strategy courses (4 q.h.)
|
BTC 6213
|
Clinical Trial Design Optimization and Problem Solving |
4 q.h. |
|
PMC 6212
|
Clinical Drug Development Data Analysis: Concepts |
4 q.h. |
|
RGA 6112
|
Biomedical Intellectual Property Management: Patents |
4 q.h. |
|
RGA 6205
|
Emerging Trends and Issues in the Medical Devices Industry |
4 q.h. |
|
RGA 6210
|
Strategic Planning and Project Management for Regulatory Affairs
|
4 q.h. |
|
RGA 6211
|
Combination Products and Convergence |
4 q.h. |
|
RGA 6215
|
Project Management in Early Drug Discovery and Development |
4 q.h. |
|
RGA 6245
|
Regulation of Generic Pharmaceutical and Biosimilar Products |
4 q.h. |
|
RGA6250
|
Financing and Reimbursement in Biomedical Product Development |
4 q.h. |
Choose from one of the following International courses (4 q.h.)
|
RGA 6220
|
Global Biotechnology Product Registration: E.U., U.S. Product Regulation |
4 q.h. |
|
RGA 6221
|
European Union Compliance Process and Regulatory Affairs |
4 q.h. |
|
RGA 6222
|
European Medical Device Regulations |
4 q.h. |
|
RGA 6223
|
Global Awareness: Canada, Asian, and Latin American Regulatory Affairs |
4 q.h. |
|
RGA 6225
|
Japanese Medical Device Regulations and Registration |
4 q.h. |
|
RGA 6226
|
Canadian and Australian Medical Device Regulations |
4 q.h. |
|
RGA 6227
|
Global Awareness: Emerging Medical Device Markets |
4 q.h. |
|
RGA 6228
|
Managing International Clinical Trials |
4 q.h. |
|
RGA 6240
|
The Evolving Indian Regulatory Landscape |
4 q.h. |
Open Electives (4 q.h.) - Some Suggested Topics:
|
COP 6940
|
Personal and Career Development
- Enrollment into this is course requires participation in the cooperative education program (subject to availability)
- Students must also take RGA 6920 (1 q.h.) to meet the 4 q.h. elective course requirement
- Effective spring 2012, all students in this program are required to complete both RGA 6100 and BTC 6210 before enrolling in COP 6940
|
3 q.h. |
|
RGA 6206
|
Practical Aspects of Regulatory Compliance |
4 q.h. |
| |
Or one course from any other category |
4 q.h. |
Total Quarter Hours: 45